D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KYTX holding history

Kyverna Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYTX overview All 13F holders of KYTX Full Q2 2026 holdings

Shares (Q2 2026): 469,346
Value: $4.18M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of KYTX by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	469,346	$4.18M	<0.1%	−252,235−35.0%	Reduced	Holders
Q1 2026	721,581	$6.23M	<0.1%	+203,069+39.2%	Added	Holders
Q4 2025	518,512	$4.87M	<0.1%	+518,512	New	Holders